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Abstract
Background: The species Himatanthus drasticus is popularly known in Northeast Brazil as “janaguba” and belongs
to the family Apocynaceae. The latex collected from its stem bark is used for several purposes including anti-
inflammatory properties and presents among its bioactive constituents the pentacyclic triterpene lupeol. The
objective of the present work was to study in vivo and in vitro the lupeol acetate (LA) isolated from the plant latex,
in several models of inflammation.
Methods: Male Swiss mice (25-30 g, 6-24 animals per group) were administered with LA, 30 min before the test
initiation. In the evaluation of analgesic activity the formalin test was used. The anti-inflammatory activity was
evaluated by the following tests: paw edema induced by carrageenan and dextran, and the carrageenan-induced
neutrophil migration into peritoneal cavities. Furthermore, the effect of LA on the myeloperoxidase release (MPO,
an inflammation biomarker) from human neutrophils was also determined, as well as its antioxidant potential by
the DPPH assay.
Results: In the formalin test, LA (10, 25 and 50 mg/kg, i.p.) inhibited both the 1
st (neurogenic, 0-5 min) and mainly
the 2
nd (inflammatory, 20-25 min) phase. Naloxone completely reversed the LA effect, indicating the participation
of the opioid system. LA also significantly inhibited carrageenan- and dextran-induced paw edemas, as well as the
neutrophil migration to the peritoneal cavity evaluated by the carrageenan-induced pleurisia. In this model, the
effect of a very low dose of LA (0.1 mg/kg) was potentiated by the same dose of pentoxifylline (PTX), a known
TNF-alpha inhibitor. LA (25 and 50 μg/ml) was also very effective in inhibiting MPO released from stimulated
human neutrophils, and significantly decreased the number of cells expressing iNOS activity in the paw of mice
submitted to carrageenan-induced edema, suggesting a drug involvement with the NO system.
Conclusions: The anti-inflammatory effect of LA probably involves the opioid system, as indicated by the
complete blockade of the opioid antagonist naloxone. Furthermore, the LA effect was potentiated by PTX (a TNF-
alpha inhibitor). LA also decreased the number of iNOS cells, suggesting the participation of pro-inflammatory
cytokines and the NO system in the drug action.
Background
Through years of ingenious syntheses and structural modi-
fications that usually follow the design and development of
new drugs, many non-steroidal anti-inflammatory agents
(NSAIDS) have been prepared and marketed [1]. However,
these drugs are known to provoke adverse effects such as
gastrointestinal irritations. Hence, the search for alterna-
tive anti-inflammatory drugs mainly from natural herbs is
required.
The species Himatanthus drasticus, popularly known
in Northeast Brazil as “janaguba”, belongs to the family
Apocynaceae. It is a tree that grows up to 7 m in height,
with dense foliage at the ends of its branches. Its geo-
graphical distribution extends from Southeast Brazil to
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occurs in several states, especially from the Northeastern
region. The latex from its stem bark is over-exploited
without control by local Brazilian communities, for
instance in the Northeasterm region of Cariri for medic-
inal purposes, mainly for the treatment of tumours,
inflammatory processes and ulcers [2].
The latex from several species of the Himatanthus
genus including H. drasticus is rich in triterpenes. These
are molecules formed by thirty carbon atoms and six
isoprenoid units (with five carbon atoms each) [3]. The
triterpenes are divided into several families with differ-
ent base structures. Lupeol, betulin, betulinic acid and
calenduladiol are triterpenes belonging to the lupane
family. As far as their biological activities are concerned,
the pentacyclic triterpenes including lupeol are a group
of promising secondary plant metabolites [4].
Lupeol is an important constituent of the species H. dras-
ticus and may be closely related to its anti-inflammatory
action. Besides pentacyclic triterpenes, H. sucuuba is
another species reported to present depsides, iridoides and
alkaloids as well [5]. Furthermore, this species has been
much more studied than H. drasticus what indicates the
importance of knowing more and better about its bioactive
constituents. Based on the popular use of H. drasticus,d u e
to its antitumor, antifungal and anti-inflammatory actions
[6], studies with this plant have been intensified. The H.
drasticus latex protein has no cytotoxic effect in vitro or
hemolytic character, but has antitumor effects in vivo [7].
The present research is aimed at evaluating the anti-
inflammatory activities of lupeol acetate (LA) isolated for
the first time from the latex of H. drasticus, on several
models of experimentally induced inflammation in mice.
Besides, the activity of LA on the MPO release from
human neutrophils was also evaluated. MPO is released
by activated neutrophils, and is a biomarker for inflam-
mation. Furthermore, to clarify the LA mechanism of
action, we studied the participation of pentoxifylline, a
PDE5 and TNF-alpha inhibitor, and morphine, a mu and
kappa agonist, on inflammatory processes, and their pos-
sible interaction with LA. Finally, histological studies (HE
staining) and the effects of LA on TNF-alpha and iNOS
were assessed by immunohistochemistry on the inflamed
mouse paw, in the carrageenan-induced edema model.
Materials and methods
Preparation and chemical characterization of lupeol
acetate (LA)
The H. drasticus latex was collected at the “Chapada do
Araripe” region (South of Ceará state) by permission of
the Brazilian Institute for the Environment and Renew-
able Natural Resources (IBAMA). The identification of
the plant was carried out through exsiccatae which were
subjected to comparison with the one already registered
(n° 31685) at the Prisco Bezerra Herbarium of the Fed-
eral University of Ceará (UFC).
Initially, the latex was submitted to a five-time extrac-
tion with ethyl acetate. The ethyl acetate extract was eva-
porated at room temperature, and then subjected to a
corn starch column chromatography under pressure. A
dichloromethane/acetone mixture with increasing polar-
ity was used as the eluent, after what a 10% yield (1 liter
of latex = 10 g) whitish solid was obtained. Next, the
solid was subjected to purification on a silica column,
using as eluent a mixture of hexane/dichloromethane in
increasing polarity. This silica purification process gave
120 fractions which were analyzed by thin-layer chroma-
tography (eluent: dichloromethane; revelation: UV lamp
and iodine). The final purification resulted in a white and
crystalline solid compound with a 93.2% purity, as deter-
mined by gravimetric analyses. Its structure was estab-
lished on the basis of spectroscopic data analysis and by
comparison with the literature data. NMR
13C data from
these crystals demonstrated that they are predominantly
lupeol acetate when compared to the literature data [5]:
(δC1 38,6; δC2 23,9; δC3 81,2; δC4 38,0; δC5 55,5; δC6 18,2;
δC7 34,4; δC8 41,0; δC9 50,5; δC10 37,2; δC11 21,1; δC12
25,2; δC13 38,2; δC14 43,0; δC15 27,6; δC16 35,7; δC17 43,0;
δC18 48,4; δC19 48,2; δC20 151,1; δC2 129,9; δC22 40,2; δC23
28,1; δC24 16,7; δC25 16,2; δC26 16,8; δC27 14,7; δC28 18,2;
δC29 109,6; δC30 19,4; δC1’ 171,2; δC2’ 21,1).
Drugs
Carrageenan (lambda type IV), dextran sulfate, naloxone
and indomethacin were purchased from Sigma Chemical
(St. Louis, MO, USA). Dexamethasone was from Aché
(Brazil), heparin from Wyeth( B r a z i l ) ,m o r p h i n ef r o m
Cristália (Brazil) and pentoxifylline from Sanofi-Aventis
(Brazil). All other reagents were of analytical grade. The
lupeol acetate (LA) was dissolved in an aqueous solution
of 1% Tween 80 (Sigma, USA), and indomethacin was
dissolved in carboxy-methylcellulose before use.
Animals
Male Swiss mice (25-30 g) were provided by the Animal
House of the Federal University of Ceará, Brazil. The
animals were housed into plastic cages with sawdust as
beddings, and kept in a room with controlled tempera-
ture (25 ± 2°C) under a 12/12 h light/dark cycle and
food and water supplied ad libitum. The experiments
were carried out accordingt ot h eG u i d ef o rt h eC a r e
and Use of Laboratory Animals of the U.S. Department
of Health and Human Services (NIH publication no. 85-
23, revised 1985). The project was previously approved
by the Animal’s Ethics Committee of the Faculty of
Medicine of the Federal University of Ceará.
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Twenty microliters of 1% formalin were administered (s.
c.) in the mouse’s right hind paw, and the licking time
was recorded from 0 to 5 min (phase 1, neurogenic) and
from 20 to 25 min (phase 2, inflammatory), after the for-
malin injection [8]. The animals were treated with saline
(0.1 mL/10 g, i.p.), morphine (7.5 mg/kg, i.p.), LA (10, 25,
and 50 mg/kg, i.p.), morphine + naloxone (7.5 and 2 mg/
kg, i.p, respectively) or LA + naloxone (50 and 2 mg/kg,
i.p., respectively), 30 min before the formalin injection.
Carrageenan-induced mice paw edema
Carrageenan-induced paw inflammation was achieved
according to the method described previously [9]. The
animals were randomly selected and divided into groups
of 6-23 animals. LA was dissolved in 1% Tween 80, and
administered at the doses of 2, 10, 20 and 50 mg/kg, i.p.
The other groups were injected with the reference drug
(indomethacin, 10 mg/kg, i.p.) or vehicle (Tween 80).
Thirty minutes later, the edema was induced by the
injection of 50 μL of 1% v/v carrageenan solution into
the animal’s right hind paw. Measurements of the paw
volume were done by means of a plethysmometer (Ugo
Basile, Italy), immediately prior to the carrageenan injec-
tion and after 1, 2, 3, 4 and 24 h. The paw edema
volume was determined by the difference between the
final and initial volumes.
Dextran-induced mice paw edema
The treatment of animals and measurements of the paw
volume (0, 1, 2, 3 and 4 h) were done as described
above. An injection of dextran (100 μg/0,1 ml/paw) was
used [10]. LA (12.5 and 25 mg/kg, i.p.), dexamethasone
(1.5 and 3 mg/kg, i.p.) and vehicle (1% Tween 80 solu-
tion) were administered to the different groups of mice,
30 min prior to the dextran injection.
In vivo carrageenan-induced neutrophil migration into
mice peritoneal cavities
Groups of 8 animals were treated with LA (0.1, 1, 10
and 20 mg/kg, i.p.), dexamethasone (5 mg/kg, i.p.) or
vehicle, 30 min before the induction of inflammation by
means of 1% carrageenan (500 μg/mL). The test was
developed according to the experimental protocol
described below [11]. All drugs were administered at a
volume of 10 mL/kg, and then the animals were
returned to their cages with free access to water. After
five hours, the peritoneal fluid was collected by abdom-
inal laparoscopy. For this, all animals were pretreated
with a heparinized saline (5 IU/ml, ip). A sample of the
peritoneal fluid was diluted 1:10 in Turk liquid for
quantification of cell number, using a Neubauer cham-
ber. For differential counting of leukocytes, the exsudate
was centrifuged at 1,000 rpm for 5 min, and 200 μLo f
3% bovine serum albumin were added to the pellet for
the preparation of slides. The cells were stained by a
conventional fast pigment, and the results expressed by
the number of cells/mm
3 (total and differential leuko-
cyte counts in the wash fluid).
Myeloperoxidase (MPO) release from human neutrophils
According to previous methods [12], 2.5 × 10
6 cells
were suspended in buffered Hank’s balanced solution,
containing calcium and magnesium. The preparations
contained predominantly neutrophils (85.0 ± 2.8%), and
the cell viability was 97.7 ± 0.94% as determined by the
Trypan-blue test. The cells were incubated with LA (0.1,
1 and μg/mL) for 15 min at 37°C, and stimulated by the
addition of phorbol myristate acetate (PMA, 0.1 μg/mL)
for 15 min at 37 °C. The suspension was centrifuged for
10 min at 2,000 × g at 4°C. Aliquots (50 μL) of the
supernatants were added to phosphate-buffered saline
(100 μL), phosphate buffer (50 μL, pH 7.0) and H2O2
(0.012%). After 5 min at 37°C, thiamine monophosphate
(TMP, 1.5 mM, 20 μL) was added, and the reaction
stopped by 30 μL of a sodium acetate solution (1.5 M,
pH 3.0). The absorbance was determined in triplicates
using a spectrophotometer (620 nm).
LDH release from human neutrophils
After isolation, a suspension of cells (5.0 × 10
6/mL) was
incubated with LA (1 to 50 μg/mL), vehicle or 0.2% Tri-
ton X-100 (known to cause cell lysis and used as a posi-
tive control), for 15 min at 37°C. Then, the LDH release
was determined according to the manufacturer’s instruc-
tions (LDH liquiform of Labtest Diagnosis, MG, Brazil).
The increasing LDH leakage was expressed by the
absorbance decrease at 340 nm.
In vitro determination of the antioxidant activity by the
DPPH (1, 1-diphenyl-2-picryl-hydrazyl) assay
The antioxidant activities of LA and alpha-tocopherol
(as standard) were determined by the DPPH assay [13].
Briefly, 0.1 mL alpha-tocopherol (from a 3 mg/mL solu-
tion, final concentration of 50 μg/mL) or LA (1, 2.5, 5
and 10 μg/mL) were placed into test tubes, followed by
the addition of 3.9 mL 0.3 mM DPPH (in a 1:1 metha-
nol solution). LA, alpha-tocopherol or vehicle (30%
DMSO in a methanol:ethanol 1:1 solution) were vigor-
ously shaken with DPPH and left standing for 60 min in
the dark. A 0.1 mL methanol:ethanol solution was used
for blank. The reduction of DPPH was spectrophotome-
trically determined at 517 nm. The radical scavenging
activity (RSA) was calculated as the percentage of the
DPPH discoloration, by the equation: % RSA = [(ADPPH
- As )/ADPPH] × 100, where As is the absorbance of the
test solution, when the compound has been added, and
ADPPH is the absorbance of the DPPH solution.
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For immunohistochemistry assays of the tumor necro-
sis factor-alpha (TNF-a) and induced nitric oxide
synthase (iNOS), the streptavidine-biotin-peroxidase
method was used [14]. Three groups of mice were
treated with distilled water; two other groups were
treated respectively with LA (50 mg/kg, i.p.) and indo-
methacin (10 mg/kg, i.p.). After 30 min, the animals
were administered with an intraplantar injection of
carrageenan. Three hours later, they were sacrificed
and 5 mm plantar region sections of the carrageenan-
injected hind paw were immersed in 10% formalin for
24 h and inserted in paraffin blocks. The sections were
then deparafinized, dehydrated in xylol and ethanol,
and immersed in 0.1 M citrate buffer (pH 6) under
microwave heating for 18 min, for antigen recovery.
After cooling at room temperature for 20 min, the sec-
tions were washed with a phosphate buffered saline
(PBS) solution, followed by a 15 min blockade of endo-
genous peroxidase with a 3% H2O2 solution. The sec-
tions were incubated overnight (4°C) with rabbit
primary antibodies (anti-TNF-a or anti-iNOS, respec-
tively) as 1:200 or 1:400 dilutions in PBS-BSA. At the
next day, the sections were washed in PBS and incu-
bated for 30 min with the secondary biotinilated rabbit
antibody (anti-IgG), 1:200 dilution in PBS-BSA. After
washing in PBS, the sections were incubated for
30 min with the conjugated streptavidin peroxidase
complex (ABC Vectastain® complex, Vector Labora-
tories, Burlingame, CA, USA). After another washing
with PBS, the sections were stained with 3,3’diamino-
benzidine-peroxide (DAB) chromophore, counter-
stained with Mayer hematoxylin, dehydrated and
mounted in microscope slides for analyses.
Statistical analysis
All results are presented as mean ± S.E.M. One-way
ANOVA followed by the Student-Newman-Keuls test
were used for comparing the results among treatments.
The significance level was set at p < 0.05.
Results
Formalin test in mice
LA (10, 25 and 50 mg/kg, i.p.) reduced both phases of
the formalin test, and the results were significant at the
two higher doses. However, the effects were mainly on
the 2
nd phase with 61% inhibition, whereas the 1
st phase
was inhibited by 41% at the LA dose of 50 mg/kg, i.p.
The naloxone pretreatment completely reversed the LA
effect, in the 1
st and 2
nd phases, indicating the participa-
tion of the opioid system in LA antinociceptive and
anti-inflammatory actions. As expected, morphine used
as the reference drug significantly decreased the 1
st
(63%) and 2
nd (91%) phases of the test, and had its effect
on both phases also reversed by naloxone. The data are
presented in Table 1.
Carrageenan-induced mouse paw edema
The pre-treatment of mice with LA (2, 5, 10 and 20 mg/
k g ,i . p . )s i g n i f i c a n t l yr e d u c e dt h ev o l u m e( μL) of the
edema, in the 1
st,2
nd,3
rd and 4
th hours after adminis-
tration of carrageenan, as compared to the control
group. The doses that showed greater effects were 10
and 20 mg/kg, which reduced the edema by 40 (1
st h),
39 (2
nd h), 45 (3
rd h), 51% (4
th h) and 47 (1
st h), 47 (2
nd
h), 43 (3
rd h), 49% (4
th h), respectively. Figure 1 shows
the LA effect at the 3
rd h, corresponding to its maxi-
mum activity.
Dextran-induced mouse paw edema
The pre-treatment of mice with LA (12.5 and 25 mg/kg,
i.p) significantly reduced the volume (μL) of the edema
in the 2
nd (31 and 41%), 3
rd (30 and 50%) and 4
th (23
and 27%) hours after administration of dextran, respec-
tively, as compared to the control group. A group that
had been treated with dexametasone (1.5 mg/kg, i.p.)
was co-administered with LA at the dose of 12.5 mg/kg,
i.p. This group had the volume (μL) of edema, on the
2
nd,3
rd and 4
th hours after the administration of dex-
tran, reduced in 49, 58 and 52%, respectively. Figure 2
shows LA effects at the 3
rd h of development of the dex-
tran-induced paw edema.
Peritonitis induced by carrageenan in mice
Figure 3 presents the LA effect on the carrageenan-
induced pleurisia. Carrageenan (1%) caused a significant
neutrophil migration when injected into the peritoneal
cavity of mice. LA injected 30 min before carrageenan
Table 1 The effect of lupeol acetate (LA) on pain
behavior in the formalin test
Group Paw licking (s)
1
st phase Inhibition 2
nd phase Inhibition
Control 64.0 ± 2.9 - 32.6 ± 3.9 -
Morphine
(7.5 mg/kg, i.p.) 23.8 ± 2.8
a 62.8 2.9 ± 1.6
a 91.1
LA (mg/kg, i.p.)
10 55.8 ± 3.6 12.8 41.2 ± 5.3 -
25 50.3 ± 4.7
a 21.4 13.8 ± 3.9
a 57.6
50 36.1 ± 2.2
a 46.5 12.6 ± 2,2
a 61.3
Morphine +
Naloxone
(7.5 + 2 mg/kg, i.p.)
LA + Naloxone
51.5 ± 5.3
b 19.5 29.1 ± 2.4
b 10.7
(50 + 2 mg/kg, i.p.) 56.4 ± 2.0
c 11.9 29.1 ± 2.5
c 10.7
Pain response was recorded between 0-5 (1
st phase) and 20-25 min (2
nd
phase). LA was administered 30 min before formalin. a. vs. control; b. vs.
morphine; c. vs. LA 50, at p < 0.05 (ANOVA followed by Student-Newman-
Keuls as the post hoc test).
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phil migration in a dose-dependent manner. The LA
inhibitory effect against carrageenan-induced migration
was about 52, 79 and 90%, at the doses of 1, 10 and 20
mg/kg, i.p., respectively. The reference drugs dexa-
methasone (5 mg/kg, i.p.) and pentoxifylline (1 and 25
mg/kg, i.p.) decreased the carrageenan-induced neutro-
phil migration by 82, 34 and 65%, respectively.
T h eg r o u p st r e a t e dw i t ha0 . 1m g / k gd o s eo fp e n t o x i f y l -
line or LA showed no significant inhibition of neutrophils
migration (15 and 5%, respectively), when compared to
controls (in the presence of carrageenan only). However,
when these drugs were co-administered at this same
dose, they promoted a significant inhibition of 37%.
LA effects on the myeloperoxidase (MPO) release from
human neutrophils in vitro
In order to evaluate the possible effect of LA on MPO,
we determined its effects on the PMA-stimulated MPO
release from human neutrophils. Our results showed
(Figure 4) that a 5.7 times increase in enzyme release
was observed in the presence of 0.4% Tween 80 (vehicle)
as compared to Hanks’ solution (negative control). On
the other hand, significant and dose-dependent inhibi-
tions were demonstrated with LA concentrations of 0.1,
1a n d1 0μg/mL, and a maximal effect was already seen
within this dose range. The effects observed with the
two higher LA doses were similar to that of indometha-
cin (10 μg/mL) used as a reference drug.
LA effects on the lactate dehydrogenase (LDH) release
from human neutrophils in vitro
The results of Figure 5 show that while Triton X-100 (a
cytotoxic drug used as positive control) increases in 7.7
times LDH release from human neutrophils, the
increase was only around 2 times in the presence of the
vehicle (0.2% Tween 80) as related to Hanks’ solution
(negative control). On the other hand, while no signifi-
cant enzyme release was observed with LA at the
Figure 1 Effects of lupeol acetate (LA: 5, 10, 25 and 50 mg/kg,
i.p.) or indomethacin (10 mg/kg, i.p.) on the paw edema
induced by carrageenan, at the 3
rd h. Each value represents the
mean ± S.E.M. of 7-23 animals per group. a. vs. control, at p < 0.05
(ANOVA followed by the Student-Newman-Keuls as the post hoc
test).
Paw edema (mL)
Control 1.5  3.0  12.5  25  1.5 + 12.5
0.00
0.05
0.10
0.15
0.20
0.25
a
a
a
a
a
Dexa LA Dexa + LA
Figure 2 E f f e c t so fl u p e o la c e t a t e( L A :1 2 . 5o r2 5m g / k g ,i . p . )
or dexametasone (1.5 or 3 mg/kg, i.p.) on the paw edema
induced by dextran, at the 3
rd h. Each value represents the mean
± S.E.M. of 5-7 animals per group. a. vs. control, at p < 0.05 (ANOVA
followed by the Student-Newman-Keuls as the post hoc test).
Number of cells/mm
3 
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Figure 3 Effects of the administration of lupeol acetate (LA:
0.1, 1, 10 and 20 mg/kg, i.p.) or pentoxifylline (0.1, 1 and 25
mg/kg, i.p.) on acute carrageenan-induced peritonitis,
measured by the number of cells in the peritoneal fluid. Each
value represents the mean ± S.E.M. of 8 animals per group. a. vs.
control, at p < 0.05 (ANOVA followed by the Student-Newman-Keuls
as the post hoc test).
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nificant LDH release (around 2 times) was detected with
the higher LA concentration (50 μg/mL), probably
related to the presence of 0.2% Tween 80.
LA shows no radical scavenging activity as evaluated by
the DPPH in vitro
In order to detect any possible antioxidant effect of LA,
t h eD P P Ha s s a yw a sp e r f o r m e d. The results show that
LA at the concentrations of 50, 100 and 200 μg/mL pre-
sents no radical scavenging capacity. On the contrary,
vitamin E used as the reference drug significantly
decreased the absorbance value, as related to controls
(Figure 6).
Histological analyses of mice paw in the carrageenan-
induced edema model
The intraplantar injection of 1% carrageenan into the rat
right hind paw produced an intense edema, character-
ized by epithelial and conjunctive tissue blisters and
infiltrates of inflammatory PMN cells, mainly neutro-
phils, as compared to the carrageenan untreated group
(normal control) (Figure 7). In the carrageenan groups
pretreated with LA (50 mg/kg, i.p.) or indomethacin
(10 mg/kg, i.p.) there were significant edema decreases
as well as decreases in inflammatory cells infiltration.
TNF-alpha immunohistochemistry and LA effects on mice
paw in the carrageenan-induced edema model
Immunohistochemistry analyses showed a great number
of cells expressing TNF-a in the paw conjunctive tissue,
mainly mononucleated cells in mice submitted to carra-
geenan-induced inflammation, as compared to the
untreated (normal controls) group (Figure 8). In the
Hanks
Tween 0,4%
g/ml

LA 0.1 g/ml

LA 1 g/ml

LA 10
Indo 10 mcg/ml
0.0
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2.0
a
a,b
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P
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c
r
e
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i
o
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Figure 4 Effects of lupeol acetate (LA: 0.1, 1 and 10 μg/ml) on
PMA stimulated myeloperoxidase (MPO) activity from human
neutrophils in vitro. The values are expressed as mean ± S.E.M. The
analysis was done at least in quadruplicates and repeated in three
different days. a. and b. vs. control (Hanks’ solution) and vehicle
(0.4% Tween 80), respectively, at p < 0.001 (ANOVA followed by the
Student-Newman-Keuls as the post hoc test).
Hanks
Tween 0.4%
LA 1
LA 10
LA 25
LA 50
Tx 100 0.2%
0
50
100
150
200
250 a
b b
L
D
H
 
(
U
/
L
)
Figure 5 Effects of lupeol acetate (LA: 10, 25, 50 μg/ml) on
lactate dehydrogenase (LDH) release from human neutrophils
in vitro. The values are expressed as mean ± S.E.M. The analysis was
done at least in quadruplicates and repeated in three different days.
a. and b. vs. control (Hanks’ solution) and vehicle (0.4% Tween 80),
respectively, at p < 0.01 to 0.001 (ANOVA followed by the Student-
Newman-Keuls as the post hoc test).
Absorbance at 517 nm
Control 50  10   25  50 100
0.0
1.0
2.0
3.0
4.0
a
LA Vit. E
Figure 6 DPPH radical scavenging activity of lupeol acetate
(LA: 10, 25, 50 and 100 μg/ml) was measured at 517 nm, as
compared to standard alpha-tocopherol (50 μg/ml). Values are
means ± S.E.M. of triplicate experiments. a. vs. control, at p < 0.05
(ANOVA followed by the Student-Newman-Keuls as the post hoc
test).
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LA (50 mg/kg, i.p.) or indomethacin (10 mg/kg, i.p.), the
reduction of TNF-a expressing cells was not significant.
iNOS immunohistochemistry and LA effects on mice paw
in the carrageenan-induced edema model
A great number of iNOS expressing cells, mainly neu-
trophils in the conjunctive tissue, was observed in the
inflamed paw after carrageenan administration, as
related to the paw of untreated mice (normal controls)
(Figure 9). In the carrageenan-treated groups pretreated
with LA (50 mg/kg, i.p.) or indomethacin (10 mg/kg,
i.p.), there were significant reductions of iNOS expres-
sing cells.
Discussion
Although the Himatanthus g e n u sp r e s e n t s1 4s p e c i e s ,
distributed in tropical and sub-tropical areas, only 5 spe-
cies were studied from chemical and/or biological points
of view. In Brazil, these studies were carried out with
species such as H. sucuuba, common to the Amazonian
region. Furthermore, very few works are found in the
literature on H. drasticus. The latex of these species is
rich in triterpenes, including lupeol of a lupane type
which was reported to present antitumor [15-18] and
anti-inflammatory activities [19-22]. Also, a recent study
[23] showed that the latex from H. sucuuba exhibited a
potent leishmanicidal activity against intracellular amas-
tigotes of Leishmania amazonensis, a causal agent of
cutaneous leshmaniasis. Moreover, this latex also
increased NO and TNF-alpha and decreased transform-
ing growth factor-beta (TGF-beta) production in
macrophages.
Lupeol is found in several other species and its antino-
ciceptive and anti-inflammatory activities have been
already demonstrated [24-28]. It is accepted that the
anti-inflammatory property of lupeol often accompany
its immune modulatory and anti-tumor action
[29,30,4,15]. Despite the wealth literature data on lupeol,
there are very few reports on lupeol acetate. It has been
recently shown that lupeol acetate presents an anti-
inflammatory activity by regulating TNF-alpha and IL-2
Figure 7 Hematoxylin-eosin stained sections of paws from mice treated with lupeol acetate (LA), in the model of carrageenan-
induced edema. A: Control (0.04% Tween 80); B: Control + Carragenan; C: Indomethacin (10 mg/kg, i.p.) + Carrageenan; D: LA (50 mg/kg, i.p.)
+ Carrageenan. All figures were magnified by 100×.
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10 mRNA [31].
The latex from H. drasticus is widely used by commu-
nities from the Brazilian Northeastern region in gastritis
and cancer among other health problems. In the present
work, we showed that lupeol acetate (LA, 93.2% purity)
isolated from the H. drasticus latex presented a potent
anti-inflammatory action, in several models of inflam-
mation in mice. Thus, LA inhibited predominantly the
formalin test 2
nd phase, indicative of an inflammatory
process. Interestingly, the LA effect was almost comple-
tely reversed by naloxone, suggesting that the effect is at
least in part dependent upon the opioid system. The
opioid participation in the LA action was further con-
firmed by the hot plate test, where its antinociceptive
effect was as in the case of morphine also reversed by
naloxone (data not shown).
LA significantly inhibited mice carrageenan- and dex-
tran-induced paw edemas. However, it was more effec-
tive in the carrageenan model which induces paw edema
and substantial leukocyte migration, mediated by hista-
mine and serotonin in the initial phase of the inflamma-
tory process, and by prostaglandin and bradykinin in
later stages. On the other hand, paw edema induced by
dextran although also mediated by histamine and sero-
tonin does not involve leukocyte migration [9,32].
Lupeol administered topically has been shown [22]
to suppress the mouse ear edema induced by 12-O-
tetradecanoyl-phorbol acetate. Besides, lupeol significantly
reduced PGE2 production from stimulated macrophages,
in vitro. These authors concluded that lupeol possessed an
anti-inflammatory activity which is probably related to its
ability to prevent the production of pro-inflammatory
mediators, such as TNF-a and IL-1b.
Furthermore, from a dose as low as 1 mg/kg, LA dras-
tically and dose-dependently inhibited the neutrophils
migration, as evaluated in the carrageenan-induced peri-
tonitis model, corroborating its effect on the carragee-
nan-induced mice paw edema. Interestingly, in our
work, LA effects were potentiated by PTX, a known
TNF-alpha inhibitor [33]. We also showed that, in the
mice paw submitted to carrageenan-induced edema, LA
significantly decreased the edema and neutrophils
migration, as compared to controls. This effect was
similar to that of indomethacin, the reference drug, as
assessed by histological techniques.
It has been observed that kappa-opioid drugs exert a
powerful anti-inflammatory effect, reducing TNF-alpha
Figure 8 Immunohistochemical staining for TNF-a of paws from mice treated with lupeol acetate (LA), in the model of carrageenan-
induced edema. A: Control (0.04% Tween 80); B: Control + Carrageenan; C: Indomethacin (10 mg/kg, i.p.) + Carrageenan; D: LA (50 mg/kg, i.p.)
+ Carrageenan. All figures were magnified by 400×.
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tion, the expression of opioid receptors has been shown to
occur during peripheral inflammation [35]. Considering
that the LA effect was potentiated by PTX (an anti-TNF-a
drug) and completely reversed by naloxone (an opioid
antagonist), we could assume that at least in part LA acts
inhibiting endogenous TNF-a. This cytokine is considered
as a key factor in several inflammatory diseases and its
regulation is mediated by transcription factors as the NF-
kappaB. Previous studies [36] demonstrated glial activation
and increased pro-inflammatory cytokines, in animal mod-
els of neuropathic pain. These authors showed that
chronic propentofylline, a glial modulating and anti-
inflammatory agent chemically similar to PTX, attenuated
the development of hyperalgesia and restored the analgesic
activity of acute morphine in neuropathic rats.
In an earlier study [37], the interactions among cyto-
kines, PGE2 and cell migration during the various
phases of carrageenan-induced acute inflammation were
evaluated in the mouse air pouch model. These authors
concluded that TNF-a seems to play an important role
in this model, particularly for leukocyte migration in the
1
st phase of the inflammatory process. It was also
demonstrated that PTX reduced histological lung injury
and pulmonary neutrophil activity, in a model of
hemorrhagic shock in rats [38], and the administration
of PTX was associated with diminished NF-kappaB and
enhanced CREB activation. In addition, in a model of
experimental acute pancreatitis in rats [39], PTX signifi-
cantly attenuated histological lung injury, pulmonary
neutrophil activity and pro-inflammatory signaling.
We showed significant inhibitions of MPO release
from human stimulated neutrophils by LA, at low con-
centrations (1 and 10 μg/mL) and effects were similar to
those seen with indomethacin, used as reference drug.
MPO is an enzyme stored in azurophilic granula of neu-
trophils, released after their activation and characterized
by powerful pro-oxidative and pro-inflammatory pro-
teins [40]. It is often used as a reliable biomarker of
inflammation [41]. Recently [42], MPO was shown to
promote lung neutrophilia and to influence indirectly
subsequent chemokine and cytokine productions by
other cell types in the lung. Furthermore, LA showed no
significant cytotoxicity up to 50 μg/mL, as assessed by
the LDH release from human neutrophils.
The administration of lupeol was reported to cause
reductions of cellularity and eosinophils in the bronch-
oalveolar fluid, as assessed by a murine model of airway
inflammation [21]. These authors showed that the treat-
ment with lupeol reduced levels of IL-4, IL-5 and IL-13,
Figure 9 Immunohistochemical staining for iNOS of paws from mice treated with lupeol acetate (LA), in the model of carrageenan-
induced edema. A: Control (0.04% Tween 80); B: Control + Carrageenan; C: Indometacin (10 mg/kg, i.p.) + Carrageenan; D: LA (50 mg/kg, i.p.) +
Carrageenan. All figures were magnified by 400×.
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Lupeol seems to be a potent anti-inflammatory and
multi-target drug, targeting key molecular pathways
such as those involving NF-kappaB, among others [43].
Previously [19], the lupeol treatment to mouse skin was
reported to result in the inhibition of TPA-induced acti-
vation of several inflammatory and tumor-promoting
factors, including NF-kappaB.
All together, our results showed that LA probably acts as
an anti-inflammatory drug by decreasing the number of
cells expressing iNOS. Although LA did not significantly
decrease the number of cells expressing TNF-a, this effect
becomes significant when LA is co-administered with
PTX, a known TNF-a inhibitor. Other triterpenes were
also shown to inhibit nitric oxide production by reducing
iNOS expression [44], while a recent work [45] reported
that the anti-inflammatory activity of these compounds is
associated to the decreased production of iNOS and pro-
inflammatory cytokines.
The oral administration of lupeol (25 to 200 mg/kg)
was also reported to produce a dose-related inhibition of
IL-2, IFN-g and TNF-a, in mice pleural exudates [46].
Interestingly, PTX was shown to decrease lung MPO
activity and NF-kappaB activation, in the model of LPS-
induced acute lung injury in rats [47]. Finally, in the pre-
sent work we showed that the anti-inflammatory effect of
LA probably involves the opioid system and is poten-
tiated by PTX. Furthermore, LA decreased the number of
iNOS cells, suggesting that pro-inflammatory cytokines
and the NO system play an active role in the drug action.
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